Cargando…
Optimizing Treatment of Familial Hypercholesterolemia in Children and Adolescents
Cardiovascular disease (CVD) is still the most prominent cause of death and morbidity in the world, and one of the major risk factors for developing CVD is hypercholesterolemia. Familial hypercholesterolemia (FH) is a dominantly inherited disorder characterized by markedly elevated plasma low-densit...
Autores principales: | Luirink, Ilse K., Hutten, Barbara A., Wiegman, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537493/ https://www.ncbi.nlm.nih.gov/pubmed/26275368 http://dx.doi.org/10.1007/s11886-015-0629-1 |
Ejemplares similares
-
Lipid Screening, Action, and Follow-up in Children and Adolescents
por: Wiegman, Albert
Publicado: (2018) -
New Approaches in Detection and Treatment of Familial Hypercholesterolemia
por: Hartgers, Merel L., et al.
Publicado: (2015) -
Polygenic Hypercholesterolemia and Cardiovascular Disease Risk
por: Sharifi, Mahtab, et al.
Publicado: (2019) -
Genetic Architecture of Familial Hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2017) -
Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy
por: Wiklund, Olov, et al.
Publicado: (2013)